TRILAFON (perphenazine) by Merck & Co. is clinical pharmacology pharmacokinetics following oral administration of perphenazine tablets, mean peak plasma perphenazine concentrations were observed between 1 to 3 hours.
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
TRILAFON (perphenazine) is an oral antipsychotic syrup indicated for the treatment of psychiatric disorders including schizophrenia and other psychotic conditions. It works as a dopamine antagonist, blocking D2 receptors in the central nervous system to reduce hallucinations, delusions, and disorganized thinking.
Pre-launch stage indicates active market preparation and commercial team building; limited competitive data suggests potential niche positioning.
CLINICAL PHARMACOLOGY Pharmacokinetics Following oral administration of perphenazine tablets, mean peak plasma perphenazine concentrations were observed between 1 to 3 hours. The plasma elimination half-life of perphenazine was independent of dose and ranged between 9 and 12 hours. In a study in…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
Worked on TRILAFON at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
TRILAFON is in pre-launch phase with zero linked job openings currently, suggesting either early-stage team building or a selective launch strategy. Joining this product offers the challenge of repositioning an established molecule in a competitive market, appealing to professionals interested in formulation innovation and market access strategy.